Skip to content

For Research & Educational Discussion Only. Not Medical Advice

BaselineForum

Melatonin

Hormone, sleep and circadian regulator

Also known as N-acetyl-5-methoxytryptamine, sleep hormone

The body's own darkness signal, sold as a sleep aid. It shifts the body clock reliably and nudges sleep onset by minutes, not hours. For chronic insomnia in adults the meta-analyses disagree, and the common dose and timing may be the wrong ones.

What doses have been studied? What each trial gave, with the population it was given to.

Guide updated Oct 22, 2026Literature checked Oct 21, 20264 curated studies28 literature recordsBaseline editorial

Overview

In shortMelatonin is the hormone your brain releases in darkness to say it is night. Two different uses share the name. Shifting the body clock, for jet lag, shift work or a bedtime that has drifted late, works and makes sense. Treating insomnia, where the clock is fine and sleep still will not come, is where the evidence is modest and the better reviews are doubtful.

Melatonin is a hormone the pineal gland releases in darkness, telling the rest of the body it is night. As a supplement it is one of the most used sleep products in the world, available on a supermarket shelf in the United States and only on prescription in most of Europe.

Two different things get called "melatonin for sleep". One is shifting the body clock: jet lag, shift work, a sleep phase that has drifted late. For that, timed melatonin has good evidence and a clear mechanism. The other is treating insomnia, where the clock is fine and sleep still will not come. For that, the evidence is modest at best and the better-designed reviews are skeptical.

Mechanism

In shortIt acts on the brain's master clock: taken in the evening it pulls the clock earlier, in the morning it pushes it later. That effect is reliable. Its direct sleep effect is separate and weaker, a small drop in temperature and alertness that brings sleep on a few minutes sooner. It is not a sedative, which is why it is safe and why it is weak.

Melatonin acts on receptors in the brain's master clock, the suprachiasmatic nucleus, and on receptors elsewhere. Taken in the evening it advances the clock; taken in the morning it delays it. That is a robust, dose-dependent effect and the basis for its use in circadian disorders.

Its direct sleep-promoting effect is separate and weaker. It lowers core body temperature and alertness modestly, which shortens the time to fall asleep by minutes. It is not a sedative in the way prescription hypnotics are, which is both its safety advantage and the reason its effect on insomnia is small.

Evidence

In shortIn 19 trials it brought sleep on about 7 minutes sooner and added about 8 minutes of sleep. For adults with chronic insomnia, a 2022 review found no clear effect, though it works in children. A 2024 analysis suggests the usual low dose just before bed may be the wrong schedule, with better results from a larger dose a few hours earlier. High-dose trials found more drowsiness, nothing serious.

It shortens sleep onset and lengthens sleep, slightly. A 2013 meta-analysis of 19 placebo-controlled trials in 1,683 people with primary sleep disorders found melatonin reduced the time to fall asleep by about 7 minutes, increased total sleep by about 8 minutes, and improved sleep quality by a small amount. Larger doses and longer trials showed larger effects on onset and duration. Those are the honest numbers: real, and small.

Chronic insomnia in adults: not clearly effective. A 2022 set of systematic reviews in Sleep Medicine Reviews covering 24 randomized trials found melatonin significantly improved sleep onset and total sleep time in children and adolescents, but in adults with chronic insomnia it did not significantly improve onset, total sleep or efficiency. The authors conclude it did not appear to be effective in adults.

Dose and timing may explain the disagreement. A 2024 dose-response meta-analysis of 26 trials found effects on onset and duration increased with dose up to about 4 mg and were larger when melatonin was taken around three hours before the intended bedtime, both at odds with the common practice of a smaller dose half an hour before bed. If that holds up, many null trials tested the wrong schedule.

Safety at higher doses. A 2022 systematic review of 79 trials using high doses found no detectable increase in serious adverse events or withdrawals, but a higher rate of drowsiness, headache and dizziness, and noted that more than a third of trials did not report adverse events at all.

Safety

In shortNext-day grogginess, headache and dizziness, more at higher doses. Long-term data are thin and almost absent for children. The practical risks are timing it before driving, and the product itself: in countries where it is a supplement, testing has found gummies with several times the labeled dose, or a fraction of it. A prescription product is at least what it says.

At usual doses melatonin is well tolerated. Next-day drowsiness, headache and dizziness are the common complaints, and they rise with dose. Long-term safety data in adults are thin because trials are short, and there are almost none in children despite widespread use.

Two practical issues outweigh the pharmacology. First, melatonin suppresses alertness, so timing it before driving or operating machinery matters. Second, in countries where it is sold as a supplement, independent testing has repeatedly found products containing far more or far less than the label states, sometimes several-fold. A prescription product has a verified dose; a gummy may not.

Regulatory status

In shortIn the United States it is a supplement on a supermarket shelf. In the UK, Europe, Australia and most of the world it is prescription-only, licensed mainly for insomnia over 55 and for children with developmental conditions. Same molecule, different rules, and the prescription version is the one with a verified dose.

Melatonin's status is split more sharply than almost any other compound here. In the United States it is a dietary supplement, sold without prescription and without regulatory review of dose or claims. In the United Kingdom, the European Union, Australia and much of the rest of the world it is a prescription medicine, licensed mainly for insomnia in people over 55 and for sleep problems in children with neurodevelopmental conditions.

The same molecule, then, is either a gummy for a toddler or a doctor's decision, depending on the country. For a reader, the relevant fact is that the prescription products have a verified content and the supplements often do not.

The literature

4 studies indexed. Findings and limitations get equal weight, on purpose.

Always check the primary source

Members area

The Melatonin literature needs an account

Everything above is free to read. What an account opens is the evidence underneath it: 4 studies with their limitations, and the regimen each trial actually reported.

  • Every study, with what it found and what it cannot show
  • The limitations, given the same weight as the findings
  • The dose each named trial administered, where recorded

Free to create. A membership is separate, and you can decide about that later.

Reading is free, an account is not the same as paying. 80 compound guides, every study with its limitations written underneath, and the regimens those trials actually used. A free account opens all of it. A membership is a separate decision, and it opens the forum. What membership costs.

The wider literature

14 indexed papers and 14 registered trials mentioning Melatonin, straight from PubMed and ClinicalTrials.gov. 12 of 14 administer it; the rest measure it. These have not been read by us. Unlike the studies above, they carry no findings and no limitations written by anyone here, because writing either would mean claiming a reading nobody has done. They are a starting point for yours.

Registered trials (14)

  1. Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy

    Tanta University2025NCT06846086

    interventionalphase3recruitingn=46

  2. Melatonin on Post Operative Pain After CS

    Benha University2025NCT07380568

    interventionalnacompletedn=60

  3. The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients

    National Nutrition and Food Technology Institute2023NCT06096558

    interventionalnaunknownn=46

  4. Effect of Melatonin in Pediatric Hemodialysis Patients

    Ain Shams University2022NCT05570526

    interventionalphase3unknownn=40

  5. Efficacy and Safety of Slenyto for Insomnia in Children With ASD

    Neurim Pharmaceuticals Ltd.2020NCT04233502

    interventionalphase3withdrawnn=0

  6. Correlation Between Melatonin Levels in Different Biological Fluids

    Istituto Auxologico Italiano2018NCT05784090

    observationalunknownn=36

  7. Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude

    Robert L. Owens2018NCT03588676

    interventionalnacompletedn=39

  8. Melatonin Study Between Diminished and Normal Responder in IVF

    Bundang CHA Hospital2017NCT03117725

    interventionalnaunknownn=100

  9. Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot Study

    Seoul National University Hospital2016NCT02836743

    interventionalphase4unknownn=30

  10. Safety Study of Melatonin in Stroke Patients

    Wolfson Medical Center2013NCT01863277

    interventionalphase4unknownn=140

  11. Efficacy of Melatonin in Patients With Severe Sepsis or Septic Shock

    Aragon Institute of Health Sciences2013NCT01858909

    interventionalphase3unknownn=110

  12. Melatonin for Prevention of Metabolic Side Effects of Olanzapine

    Guilan University of Medical Sciences2012NCT01593774

    interventionalphase2completedn=36

  13. Circadian Rhythm of Erythropoietin And Melatonin in Renal Disease

    Meander Medical Center2007NCT00698360

    observationalcompletedn=34

  14. Melatonin Levels in Smith Magenis Syndrome (SMS)

    Oregon Health and Science University1998NCT00691574

    interventionalnaterminatedn=5

Papers (14)

  1. Melatonin and the Cardiovascular System.

    Manolis AA, et al.Cardiology in review2026PMID 42121279

    journal article

  2. Melatonin: the placental antioxidant and anti-inflammatory.

    Joseph TT, et al.Frontiers in immunology2024PMID 38361952

    journal articlereviewresearch support, n.i.h., extramural

  3. Melatonin Ameliorates Depressive-Like Behaviors in Ovariectomized Mice by Improving Tryptophan Metabolism via Inhibition of Gut Microbe Alistipes Inops.

    Zheng KY, et al.Advanced science (Weinheim, Baden-Wurttemberg, Germany)2024PMID 38978348

    journal articleresearch support, non-u.s. gov't

  4. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology.

    Maffei MEInternational journal of molecular sciences2020PMID 33375373

    journal articlereview

  5. A review of sleep disorders and melatonin.

    Xie Z, et al.Neurological research2017PMID 28460563

    journal articlereview

  6. Distinct roles of N-acetyl and 5-methoxy groups in the antiproliferative and neuroprotective effects of melatonin.

    Letra-Vilela R, et al.Molecular and cellular endocrinology2016PMID 27402602

    journal articleresearch support, non-u.s. gov't

  7. Melatonin in aging women.

    Gursoy AY, et al.Climacteric : the journal of the International Menopause Society2015PMID 26029988

    journal articlereview

  8. Melatonergic drugs in development.

    Carocci A, et al.Clinical pharmacology : advances and applications2014PMID 25258560

    journal articlereview

  9. Perioperative melatonin use.

    Jarratt JAnaesthesia and intensive care2011PMID 21485664

    journal articlereview

  10. Development and validation of a high throughput direct radioimmunoassay for the quantitative determination of serum and plasma melatonin (N-acetyl-5-methoxytryptamine) in mice.

    Welp A, et al.Journal of immunological methods2010PMID 20363223

    journal articlevalidation study

  11. Effects of a single dose of N-Acetyl-5-methoxytryptamine (Melatonin) and resistance exercise on the growth hormone/IGF-1 axis in young males and females.

    Nassar E, et al.Journal of the International Society of Sports Nutrition2007PMID 17956623

    journal article

  12. Pharmacological aspects of N-acetyl-5-methoxytryptamine (melatonin) and 6-methoxy-1,2,3,4-tetrahydro-beta-carboline (pinoline) as antioxidants: reduction of oxidative damage in brain region homogenates.

    Pless G, et al.Journal of pineal research1999PMID 10340726

    comparative studyjournal articleresearch support, non-u.s. gov't

  13. Suppression of UV-induced erythema by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose response study.

    Bangha E, et al.Archives of dermatological research1996PMID 8874746

    clinical trialjournal articlerandomized controlled trialresearch support, non-u.s. gov't

  14. Mechanism of melatonin action.

    Vanĕcek JPhysiological research1991PMID 1931914

    editorial

Discussion

Melatonin has its own forum, and sits in Sleep & Recovery. Every post says what kind of claim it makes.

Nobody has posted about Melatonin yet.

Membership

Supplements are free. The argument is for members.

The guide above is open to everyone, and the literature underneath it opens with a free account. That is the educational half of this site. Reading and joining the discussion around Melatonin, and every other entry, is what membership pays for.

Unlock membershipSign in

From $3.33 a month, billed annually. Cancel anytime.

For Research & Educational Discussion Only. Not Medical Advice

This guide is educational reference material compiled from published literature. It is not medical advice, not a recommendation, and not a substitute for a clinician who knows your history. Nothing here should be used to make a decision about your own health without one.

Talk to a licensed healthcare professional.